CASE REPORT: Combined Treatment with Ursodeoxycholic Acid and Pioglitazone in a Patient with Nash Associated with Type 2 Diabetes and Psoriasis

Author： Itoh Susumu Kanazuka Azuma Akimoto Takahide

Publisher： Springer Publishing Company

ISSN： 0163-2116

Source： Digestive Diseases and Sciences, Vol.48, Iss.11, 2003-11, pp. : 2182-2186

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Spotlight on Pioglitazone in Type 2 Diabetes Mellitus

By Waugh John Keating Gillian M. Plosker Greg L. Easthope Stephanie Robinson Dean M.

Treatments in Endocrinology, Vol. 5, Iss. 3, 2006-01 ,pp. : 189-191

Adis International

Access to resources Recommend Favorite

Effect of Pioglitazone on Serum Uric Acid Levels in Newly Diagnosed, Drug-Naïve Patients with Type 2 Diabetes

By Kutoh Eiji Hori Tadataka

Endocrine Research, Vol. 38, Iss. 3, 2013-08 ,pp. : 151-159

Informa Healthcare

Access to resources Recommend Favorite

Gender differences in non-glycemic responses to improved insulin sensitivity by pioglitazone treatment in patients with type 2 diabetes

By Arnetz Lisa Dorkhan Mozhgan Alvarsson Michael Brismar Kerstin Ekberg Neda

Acta Diabetologica, Vol. 51, Iss. 2, 2014-04 ,pp. : 185-192

Springer Publishing Company

Access to resources Recommend Favorite

Combined Rifampicin and Ursodeoxycholic Acid Treatment Does Not Amplify Rifampicin Effects on Hepatic Detoxification and Transport Systems in Humans

Digestion, Vol. 86, Iss. 3, 2012-09 ,pp. : 244-249

Karger

Access to resources Recommend Favorite

The Case for Combination Therapy as First-Line Treatment for the Type 2 Diabetic Patient

By Bell David S.H.

Treatments in Endocrinology, Vol. 5, Iss. 3, 2006-01 ,pp. : 131-137

Adis International

Access to resources Recommend Favorite